| Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (NCT04115306) | Phoenix Molecular Designs | 2019-11-14 |
| Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia (NCT04232241) | Universitätsklinikum Hamburg-Eppendorf | 2019-11-14 |
| Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft (NCT02878694) | University Hospital, Caen | 2019-11-14 |
| Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis (NCT04170504) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2019-11-14 |
| NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) (NCT04148391) | Aptinyx | 2019-11-14 |
| A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. (NCT04225897) | Pfizer | 2019-11-13 |
| ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT04159896) | Barbara Ann Karmanos Cancer Institute | 2019-11-13 |
| Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides (NCT04101331) | Affimed GmbH | 2019-11-13 |
| Nivolumab for Recurrent/Metastatic Carcinosarcoma (NCT05224999) | Yonsei University | 2019-11-13 |
| Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma (NCT03896113) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-11-13 |
| Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (NCT04070443) | Centre Leon Berard | 2019-11-13 |
| TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab (NCT03856099) | PharmAbcine | 2019-11-13 |
| A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients (NCT03821272) | University of Arkansas | 2019-11-13 |
| Symptom Clusters in Children With Exacerbation-prone Asthma (NCT04002362) | Emory University | 2019-11-13 |
| Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma (NCT03652441) | University of Cologne | 2019-11-13 |
| A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx (NCT04083222) | Ionis Pharmaceuticals, Inc. | 2019-11-13 |
| Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers (NCT03801915) | National Cancer Institute (NCI) | 2019-11-13 |
| A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies (NCT03888105) | Regeneron Pharmaceuticals | 2019-11-13 |
| The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover (NCT04403698) | University Hospital, Ghent | 2019-11-13 |
| Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) (NCT03891576) | Mario Negri Institute for Pharmacological Research | 2019-11-13 |
| Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock (NCT04055909) | Inotrem | 2019-11-13 |
| A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC (NCT04024813) | Gilead Sciences | 2019-11-12 |
| Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer (NCT03546686) | University of Texas Southwestern Medical Center | 2019-11-12 |
| Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine (NCT04138615) | University of Texas Southwestern Medical Center | 2019-11-12 |
| Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis (NCT04135417) | Humacyte, Inc. | 2019-11-12 |
| TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL) (NCT04163718) | H. Lee Moffitt Cancer Center and Research Institute | 2019-11-12 |
| A Study of Imlifidase in Patients With Guillain-Barré Syndrome (NCT03943589) | Hansa Biopharma AB | 2019-11-12 |
| Study to Find Out the Optimal Dose of Caffeine in the Combination Tablet of Naproxen Sodium and Caffeine in Patients Experiencing Moderate to Severe Pain After Having Wisdom Teeth Removed (NCT04132336) | Bayer | 2019-11-12 |
| Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer (NCT04182724) | Chinese PLA General Hospital | 2019-11-12 |
| Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol (NCT04145375) | Zenith Epigenetics | 2019-11-12 |
| Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia (NCT04147858) | Aptinyx | 2019-11-12 |
| First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. (NCT04097002) | Orca Therapeutics B.V. | 2019-11-12 |
| Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE) (NCT03964792) | Assistance Publique - Hôpitaux de Paris | 2019-11-12 |
| Tuberculosis Clinical Trials Consortium Study 35 (NCT03730181) | Centers for Disease Control and Prevention | 2019-11-12 |
| Clinical Study of GH001 in Depression (NCT04698603) | GH Research Ireland Limited | 2019-11-12 |
| Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN) (NCT04146896) | Aptinyx | 2019-11-12 |
| Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC (NCT05277844) | Tata Memorial Hospital | 2019-11-11 |
| Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN (NCT04034225) | Sensei Biotherapeutics, Inc. | 2019-11-11 |
| Preemptive Oral Gabapentin 600 mg in Reducing Morphine Requirement After Non Obstetric Lower Abdominal Surgery (NCT04434430) | Indonesia University | 2019-11-11 |
| Omalizumab to Accelerate a Symptom-driven Multi-food OIT (NCT04045301) | Philippe Bégin | 2019-11-11 |
| Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors (NCT04140500) | Hoffmann-La Roche | 2019-11-11 |
| Study of DF1001 in Patients With Advanced Solid Tumors (NCT04143711) | Dragonfly Therapeutics | 2019-11-11 |
| Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil (NCT03884465) | Liquidia Technologies, Inc. | 2019-11-11 |
| Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy (NCT04164888) | Civi Biopharma, Inc. | 2019-11-11 |
| Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis (NCT04109144) | Montefiore Medical Center | 2019-11-11 |
| Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty (NCT03977454) | Yale University | 2019-11-11 |
| The CHAPS Trial: Combined HIV Adolescent PrEP and Prevention (NCT03986970) | Wits Health Consortium (Pty) Ltd | 2019-11-11 |
| Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma (NCT03941795) | Peking University Cancer Hospital & Institute | 2019-11-11 |
| Intra-pocket Application of Tea Tree Oil Gel in the Treatment of Stage-2 Periodontitis (NCT04769271) | Alexandria University | 2019-11-10 |
| Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer (NCT04231552) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-11-10 |
| The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis (NCT03164083) | SCARM Institute, Tabriz, Iran | 2019-11-10 |
| Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion (NCT04340284) | Dr. Himanshu Bansal Foundation | 2019-11-10 |
| TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma (NCT05555316) | Sun Yat-sen University | 2019-11-10 |
| A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults (NCT04121143) | Jiangsu HengRui Medicine Co., Ltd. | 2019-11-09 |
| PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate (NCT03900637) | Seoul National University Hospital | 2019-11-08 |
| NR in Chemo-induced Peripheral Neuropathy (NCT03642990) | Donna Hammond, PhD | 2019-11-08 |
| Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects (NCT04129528) | Novartis Pharmaceuticals | 2019-11-08 |
| Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia (NCT03817398) | Children's Oncology Group | 2019-11-08 |
| Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (NCT04038970) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-11-08 |
| The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking (NCT04084860) | New York State Psychiatric Institute | 2019-11-08 |
| A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma (NCT04133636) | Janssen Research & Development, LLC | 2019-11-07 |
| Intranasal TXA for Anterior Epistaxis in the Emergency Department (NCT04054687) | Mercy Health Ohio | 2019-11-07 |
| Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia (NCT04143724) | Celgene | 2019-11-07 |
| Statin Treatment for UnruptureD Intracranial anEurysms Study (NCT04149483) | Beijing Neurosurgical Institute | 2019-11-07 |
| Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer (NCT06161792) | Yung Shin Pharm. Ind. Co., Ltd. | 2019-11-07 |
| Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy (NCT04025632) | Ra Pharmaceuticals | 2019-11-07 |
| Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis (NCT04160091) | Pacira Pharmaceuticals, Inc | 2019-11-07 |
| Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression (NCT04180371) | BicycleTx Limited | 2019-11-07 |
| Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients (NCT04164238) | First Affiliated Hospital of Zhejiang University | 2019-11-07 |
| Study of Safety and Immunogenicity of BVRS-GamVac (NCT04130594) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-11-07 |
| A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis (NCT04162899) | Reistone Biopharma Company Limited | 2019-11-06 |
| Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis (NCT04060979) | Beyond Air Inc. | 2019-11-06 |
| A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection (NCT04129554) | Janssen Sciences Ireland UC | 2019-11-06 |
| Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response (NCT04150341) | Theravance Biopharma | 2019-11-06 |
| Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults (NCT02741128) | Sanofi Pasteur, a Sanofi Company | 2019-11-06 |
| Gene Therapy for APOE4 Homozygote of Alzheimer's Disease (NCT03634007) | Lexeo Therapeutics | 2019-11-06 |
| Evaluation of Dexketoprofen in Total Knee Arthroplasty (NCT04161690) | KAT General Hospital | 2019-11-06 |
| Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS) (NCT04174716) | Idience Co., Ltd. | 2019-11-06 |
| Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: (NCT03875573) | Jules Bordet Institute | 2019-11-06 |
| IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia (NCT04086264) | AbbVie | 2019-11-06 |
| Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer (NCT04407988) | Hunan Cancer Hospital | 2019-11-06 |
| Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor (NCT03707262) | Jeffrey Veale, MD | 2019-11-06 |
| Study of Safety and Immunogenicity of BVRS-GamVac-Combi (NCT04128059) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-11-06 |
| Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease (NCT04070378) | Marc L Gordon, MD | 2019-11-06 |
| Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants (NCT04126213) | GlaxoSmithKline | 2019-11-05 |
| Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome (NCT04371939) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-11-05 |
| A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women (NCT04138056) | GlaxoSmithKline | 2019-11-05 |
| Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population (NCT02076672) | Ontario Clinical Oncology Group (OCOG) | 2019-11-05 |
| In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days (NCT04022889) | Cerus Corporation | 2019-11-05 |
| Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects (NCT04181476) | Henry Ford Health System | 2019-11-05 |
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (NCT04065399) | Syndax Pharmaceuticals | 2019-11-05 |
| A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer (NCT04053205) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2019-11-05 |
| Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT (NCT04168528) | Universitair Ziekenhuis Brussel | 2019-11-05 |
| Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia (NCT04948008) | Shenzhen People's Hospital | 2019-11-05 |
| A Study Investigating the Effect of Floradapt Mature Immune Defense on Nutrient Uptake and Digestive Health in a Healthy Elderly Population (NCT04147923) | Kaneka Americas Holding Inc. | 2019-11-05 |
| A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele (NCT04126473) | Eloxx Pharmaceuticals, Inc. | 2019-11-05 |
| This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. (NCT03968419) | Novartis Pharmaceuticals | 2019-11-05 |
| Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma (NCT04002401) | Kite, A Gilead Company | 2019-11-05 |
| Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration (NCT04126317) | Regeneron Pharmaceuticals | 2019-11-04 |
| Cholera Anti-Secretory Treatment Trial (NCT04150250) | PATH | 2019-11-04 |